Advisory & Diligence for Med-Tech, Radiology AI, and Advanced Materials
Operator-grade analysis through a clinical lens. Clear risks. Clear next steps. No fluff.
We provide research and product guidance—not medical, legal, or financial advice.
What you get
- Evidence-first review of claims and clinical feasibility
- Workflow fit analysis — what clinicians will actually use
- Regulatory and reimbursement constraints — what breaks adoption
- Competitive landscape and differentiation — what's defensible
- Clear risk register + what would change the conclusion
Three ways to work with us
Evidence & Risk Memo
Best for: founders, investors, and teams who need clarity fast
- Evidence synthesis with citations
- Adoption / workflow fit assessment
- Regulatory + reimbursement constraints
- Competitive snapshot
- Key risks + failure modes
Turnaround: typically 3–10 days (depending on scope)
Request a memo quoteClinical Product Spec Sprint
Best for: practices and teams that want a workflow tool built
- 60–90 min intake call
- Requirements + workflow mapping
- Feature set + prioritized roadmap
- Integration needs (none / SSO / EHR)
- Build plan + timeline + budget range
Advisory (Selective)
Best for: high-stakes projects where ongoing input changes the outcome
- Roadmap and positioning for clinician adoption
- Demo and pitch refinement for hospitals / investors
- Ongoing design and workflow feedback
Reserved for teams with active execution and clear deliverables.
Submit requestFocus areas
Med-Tech diligence
Clinical feasibility, user fit, and adoption risks for devices in IR/OR/procedural medicine.
Radiology & procedural AI
Where AI adds real utility vs. where it creates risk, liability, or workflow drag.
Graphene & advanced materials
Commercialization pathways, realistic use cases, and partner strategy.
Licensing strategy
Defensibility of IP, partner shortlist, outreach structure, and deal pathway clarity. Coordinated with qualified partners as needed.
When needed, we connect teams with specialized validation partners (e.g., biocompatibility testing and relevant labs) to accelerate credible proof.
Who this is for
- Founders building clinician-facing products
- Teams preparing for pilots, demos, or fundraising
- Investors who want a clinical reality check before allocating capital
- Practices exploring workflow tools for documentation, coding, or prior auth
Start here
Pick the path that matches your need. If you're unsure, choose "Memo" for analysis or "Build" for software.
Frequently asked questions
Do you provide financial advice?
No. We provide research, analysis, and product guidance. We do not provide investment, financial, legal, or medical advice. See our Terms of Service for details.
Do you need access to patient data?
No. Do not submit Protected Health Information (PHI). Our analysis is based on published evidence, clinical workflows, and product specifications — not patient records.
Do you integrate with hospital systems?
Custom builds can include integration planning (SSO, EHR, PACS). Start with a Spec Sprint to map requirements and identify the right integration pathway.
What's the difference between a Memo and a Spec Sprint?
A Memo is a written analysis — evidence, risks, competitive landscape. A Spec Sprint is a discovery process for building software — requirements, features, roadmap, and budget. Choose Memo for diligence, Sprint for product planning.
How do I know which option to pick?
If you need to understand risk before making a decision, start with a Memo. If you need a tool built for your practice or team, start with a Spec Sprint. If neither fits, submit a general request and we'll point you in the right direction.
Related: Evidence & Risk Memos · Tools · Contact / Intake
Written and reviewed by Pouyan Golshani, MD, Interventional Radiologist — Last updated August 27, 2025